| 1/11 | US=103 / Câncer Missailidis S. Combinatorial approaches to anticancer drug design. In: ___. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 17-28. ISBN 978-0-470-72303-6. DROGAS ANTICANCER; TECNOLOGIA DE EXIBICAO DE FAGOS; TECNICA DE SELECAO DE APTAMEROS; TECNICA SELEX |
| 2/11 | US=103 / Câncer Alcaro S, Artese A, Ortuso F. Rational approaches to anticancer drug design/in silico drug development. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 29-46. ISBN 978-0-470-72303-6. DESENVOLVIMENTO DE DROGAS IN SILICO; DROGAS ANTICANCER; ALVOS DE DNA; ALVOS DE ENZIMAS; ALVOS DE PROTEINAS |
| 3/11 | US=9 / Pediatria Adamson PC, Balis FM, Berg S, Blaney SM. General principles of chemotherapy. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 290-365. ISBN 978-0-7817-5492-7. ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; QUIMIOTERAPIA; FARMACOLOGIA CLINICA; DROGAS ANTICANCER; AGENTES ALQUILANTES; ANTIMETABOLITOS; ANTIBIOTICOS ANTITUMOR; PRODUTOS VEGETAIS; CORTICOSTEROIDES; ASPARAGINASE; RETINOIDES; SISTEMA NERVOSO CENTRAL |
| 4/11 | US=47 / Câncer Sarli V, Giannis A. Kinesin motor inhibitors as effective anticancer drugs. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 207-26. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES KINESIN; DROGAS ANTICANCER; KINESINAS; ANTIMITOTICOS; EG5 HUMANA |
| 5/11 | US=57 / Biol/Mol Weinberg RA. Tratamento racional do câncer. In: ___. A biologia do câncer. Porto Alegre: Artmed, 2008. p. 725-96. ISBN 978-85-363-1348-1. TRATAMENTO RACIONAL DO CANCER; DROGAS ANTICANCER; INIBIDORES DE PROTEASSOMAS |
| 6/11 | US=58 / Câncer Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER |
| 7/11 | US=80 / Biol/Mol Jain KK. Tumor proteomics: oncoproteomics for personalized management of cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 81-99. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. MICROARRAYS DE PROTEINA; DROGAS ANTICANCER; BIOMARKETING; CANCER; ONCOPROTEOMICS; MEDICINA PERSONALIZADA; FARMACOGENOMICA; PHARMACOPROTEOMICS; PERFIL DE PROTEINAS; PROTEOMICA |
| 8/11 | US=58 / Biol/Mol Shields AF, Price P. Role of imaging in cancer treatment. In: ___. In vivo imaging of cancer therapy. New Jersey: Humana Press, 2007. p. 1-12. (Cancer Drug Discovery and Development) ISBN 978-1-58829-633-7. TRATAMENTO DO CANCER. PAPEL DA IMAGEM; TERAPIA DO CANCER; CANCER DE IMAGENS; RESPOSTA AO TRATAMENTO DE IMAGENS; IMAGEM EM TRATAMENTO DE RADIOTERAPIA; DROGAS ANTICANCER |
| 9/11 | US=92 / Biol/Mol Kaufmann SH. Apoptosis and alternative modes of cell death: the intrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 3-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CASPASES; CARCINOGENESE; BCL-2; AIP; RESISTENCIA AS DROGAS; DROGAS ANTICANCER |
| 10/11 | US=8 / Quimioterapia Blaszkowsky LS, Erlichman C. Carcinogenesis of anticancer drugs. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 70-90. ISBN 978-0-7817-5628-6. DROGAS ANTICANCER; CARCINOGENESE; CARCINOGENOS QUIMICOS; AGENTES ANTINEOPLASICOS |
| 11/11 | US=8 / Quimioterapia Mrugala MM, Batchelor TT, Supko JG. Delivering anticancer drugs to brain tumors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 484-501. ISBN 978-0-7817-5628-6. DROGAS ANTICANCER; TUMORES CEREBRAIS; BARREIRA SANGUE-CEREBRO; ENTREGA DE DROGAS; INTERACAO MEDICAMENTOSA |